[Progress in c-di-GMP inhibitors].

Area of Science:

• Microbiology
• Bacterial Signal Transduction
• Drug Discovery

Background:

• Cyclic di-GMP (c-di-GMP) acts as a vital second messenger in bacteria.
• This molecule regulates critical cellular processes including cell differentiation, biofilm formation, and the production of virulence factors.
• Understanding c-di-GMP signaling is essential for developing new antibacterial strategies.

Purpose of the Study:

• To review small molecules developed as inhibitors of c-di-GMP related enzymes.
• To explore the potential of targeting the c-di-GMP pathway for new antibacterial agent development.
• To indicate future perspectives for c-di-GMP inhibitors in combating bacterial infections.

Main Methods:

• Literature review of small molecules targeting c-di-GMP related enzymes.
• Analysis of the three primary targets within the c-di-GMP regulated signal pathway: synthases, degrading enzymes, and receptors.
• Synthesis of current research on inhibitors and their potential applications.

Main Results:

• Several small molecules have been developed to inhibit enzymes involved in c-di-GMP metabolism.
• The review highlights the progress in developing inhibitors for c-di-GMP synthases and degrading enzymes.
• Potential therapeutic strategies targeting c-di-GMP receptors are also discussed.

Conclusions:

• Inhibiting c-di-GMP signal conduction is a viable approach for novel antibacterial drug discovery.
• Targeting c-di-GMP synthases, degrading enzymes, or receptors offers distinct therapeutic avenues.
• Further research into c-di-GMP inhibitors holds significant promise for addressing bacterial resistance.